Foxp3-deficient regulatory T cells do not revert into conventional effector CD4+ T cells but constitute a unique cell subset
- Michal Kuczma,
- Robert Podolsky,
- Nikhil Garge,
- Danielle Daniely,
- ,
- Leszek Ignatowicz
- Augusta University,
- ,
Open access
Abstract
Homeostasis in the immune system is maintained by specialized regulatory CD4+ T cells (Treg) expressing transcription factor Foxp3. According to the current paradigm, high-affinity interactions between TCRs and class II MHC-peptide complexes in thymus "instruct" developing thymocytes to up-regulate Foxp3 and become Treg cells. However, the loss or down-regulation of Foxp3 does not disrupt the development of T reg cells but abrogates their suppressor function. In this study, we show that Foxp3-deficient Treg cells in scurfy mice harboring a null mutation of the Foxp3 gene retained cellular features of Treg cells including in vitro anergy, impaired production of inflammatory cytokines, and dependence on exogenous IL-2 for proliferation and homeostatic expansion. Foxp3-deficient Treg cells expressed a low level of activation markers, did not expand relative to other CD4+ T cells, and produced IL-4 and immunomodulatory cytokines IL-10 and TGF-β when stimulated. Global gene expression profiling revealed significant similarities between T reg cells expressing and lacking Foxp3. These results argue that Foxp3 deficiency alone does not convert Treg cells into conventional effector CD4+ T cells but rather these cells constitute a distinct cell subset with unique features.
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 3731-3741 (11 pages)Journal (Volume, Issue Number)
Journal of Immunology (Volume 183, Issue 6)Publication milestones
- Published - 09/15/2009
Publication status
ISSN
0022-1767Publication IDs
- Scopus: 70349310112
- PubMed: 19710455
